2026 Inflammatory Bowel Disease (IBD) Fellowship – United States
Pfizer's IBD Fellowship Grant funds US institutions to train gastroenterologists in innovative, equity-focused IBD research and care, emphasizing DEI and advanced technologies to improve patient outcomes.
Funder: Pfizer Inc.
Due Dates (Anticipated): April 2027
Funding Amounts: Up to $80,000 for a one-year fellowship; direct salary and benefits only, no indirect costs allowed.
Summary: Supports US institutions with IBD fellowship programs that advance diversity, equity, and innovative training in IBD care and research.
Key Information: Awarded to institutions (not individuals); focus on underserved regions and health equity.
Description
This grant provides funding to US-based accredited academic institutions offering fellowship programs for gastroenterologists and physicians specializing in inflammatory bowel disease (IBD). The program emphasizes the advancement of diversity, equity, and inclusion (DEI), healthcare equity, clinical practice, research, education, and the standard of care in IBD. Preference is given to programs in underserved regions, those addressing workforce challenges, and institutions committed to health equity initiatives and comprehensive mentorship. Innovative approaches such as intestinal ultrasound (IUS), AI endoscopy, and machine learning are encouraged. The award aims to support the next generation of IBD specialists and improve patient outcomes through expert training and research.
